When tested in mice, the compound—named BBI-2779—shrank gastric tumors and prevented the cancer from developing resistance to ...

When mice with prostate cancer are given menadione, it interferes with the cancer’s survival processes. Trotman’s team ...

Prostate cancer is a quiet killer. In most men, it's treatable. However, in some cases, it resists all known therapies and ...

Along with defending against pathogens, the body’s innate immune system helps to protect the stability of our genomes in ...

Cold Spring Harbor Laboratory Professor Lloyd Trotman and his team have discovered that menadione kills prostate cancer cells ...

Antibodies show promise as candidates for therapeutics as well as tools for advancing mechanistic studies of the HER family receptors.

This first successful treatment of tumors with radioactive ion beams could one day lead to treating human patients’ tumors with millimeter precision.

Patients with advanced cancer often face a difficult journey with limited treatment options. Standard therapies—like ...

A team of molecular biologists and other medical specialists at Cold Spring Harbor Laboratory in New York, working with a ...

Along with defending against pathogens, the body's innate immune system helps to protect the stability of our genomes in unexpected ways -- ways that have important implications for the development of ...

Scientists found the compound, also known as vitamin K3, triggered some of the prostate cancer cells in mice to burst and die ...

Hepatoblastoma is the most common pediatric liver cancer and has limited therapeutic options, with platin-based therapy ...